KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Xylem (XYL) EBIAT (2016 - 2025)

Xylem has reported EBIAT over the past 16 years, most recently at $335.0 million for Q4 2025.

  • Quarterly results put EBIAT at $335.0 million for Q4 2025, up 2.76% from a year ago — trailing twelve months through Dec 2025 was $956.0 million (up 7.42% YoY), and the annual figure for FY2025 was $957.0 million, up 7.53%.
  • EBIAT for Q4 2025 was $335.0 million at Xylem, up from $226.0 million in the prior quarter.
  • Over the last five years, EBIAT for XYL hit a ceiling of $335.0 million in Q4 2025 and a floor of $82.0 million in Q3 2021.
  • Median EBIAT over the past 5 years was $150.5 million (2022), compared with a mean of $164.6 million.
  • Peak annual rise in EBIAT hit 264.52% in 2021, while the deepest fall reached 23.65% in 2021.
  • Xylem's EBIAT stood at $113.0 million in 2021, then skyrocketed by 31.86% to $149.0 million in 2022, then soared by 78.52% to $266.0 million in 2023, then rose by 22.56% to $326.0 million in 2024, then rose by 2.76% to $335.0 million in 2025.
  • The last three reported values for EBIAT were $335.0 million (Q4 2025), $226.0 million (Q3 2025), and $226.0 million (Q2 2025) per Business Quant data.